Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (714) Ultracet (acetaminophen and tramadol HCl), Ortho-McNeil Pharmaceutical,
...Newly Approved Drug Therapies (714) Ultracet (acetaminophen and tramadol HCl), Ortho-McNeil Pharmaceutical, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Ultracet (acetaminophen and tramadol HCl) Company: Ortho-McNeil Pharmaceutical Approval Status: Approved August 2001 Treatment Area: Acute pain General ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (700), Lower Back Pain
...other opioids. January 21, 2002 Phase III trial results indicate that Biovail's extended release tramadol formulation (Tramadol ER) produces statistically significant dose-related reductions in chronic low back pain. The trial included ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (19), Chronic Back Pain
...diabetic neuropathy. January 21, 2002 Phase III trial results indicate that Biovail's extended release tramadol formulation (Tramadol ER) produces statistically significant dose-related reductions in chronic low back pain. The trial included ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (45), Chronic Pain
...Latin America. February 2, 2004 Labopharm reported mixed results from two phase III trials investigating tramadol , a once-daily formulation analgesic for the treatment of osteoarthritis pain. In trial MDT3-003, tramadol achieved statistical significance for the three co-primary endpoints, which were reduction in pain, improvement ...
View Page

5.  Study Posting (3333) Trial #59680, Chronic Back Pain, Anaheim, CA
...medications daily during the past 30 days prior to screening: NSAID, COX-2 inhibitor, acetaminophen, tramadol, or opiod • Patient is able to ambulate at least 100 meters • No history of cardiac ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (565), Post-Surgical Pain
...primary efficacy endpoint, with high-dose bicifadine demonstrating non-inferiority to active-controlled therapy with tramadol, and both demonstrated statistical and clinical superiority to placebo in the sum of the pain ...
...also met their secondary endpoints including superiority to placebo for both high-dose bicifadine and tramadol in total of the pain relief scores (TOTPAR-8; p=0.01), the sum of ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (109), Osteoarthritis
...Hong Kong. February 2, 2004 Labopharm reported mixed results from two phase III trials investigating tramadol , a once-daily formulation analgesic for the treatment of osteoarthritis pain. In trial MDT3-003, tramadol achieved statistical significance for the three co-primary endpoints, which were reduction in pain, improvement ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (3), Acute and Chronic Dental Pain
...three dose levels of bicifadine (200, 400 and 600 mg) and one dose level of tramadol (100 mg) compared to placebo. September 16, 2002 Intranasal Ketamine demonstrated positive phase I/II ...
View Page

9.  CenterWatch: Neurology Approved Drug Therapies
...mild to moderate dementia of the Alzheimer's type, Approved February 2001 Ultracet (acetaminophen and tramadol HCl) ; Ortho-McNeil Pharmaceutical; For the short-term management of acute pain, Approved August 2001 ...
View Page

10.  CenterWatch: List of Newly Approved Drug Thearapies
...mild to moderate dementia of the Alzheimer's type, Approved February 2001 Ultracet (acetaminophen and tramadol HCl) ; Ortho-McNeil Pharmaceutical; For the short-term management of acute pain, Approved August 2001 ...
View Page